Cormorant Asset Management, LP - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$3,218,000
-53.9%
100,000
-33.3%
0.25%
-40.5%
Q4 2021$6,984,000
-10.3%
150,000
-48.0%
0.42%
+31.3%
Q3 2021$7,785,000
+5.3%
288,3300.0%0.32%
+25.9%
Q2 2021$7,396,000
-27.9%
288,330
-3.9%
0.25%
+10.1%
Q1 2021$10,254,000
+1.1%
300,0000.0%0.23%
-5.4%
Q4 2020$10,146,000
+17.5%
300,000
-14.3%
0.24%
-27.4%
Q3 2020$8,635,000350,0000.33%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$52,174,00019.87%
MPM BioImpact LLC 1,745,943$33,260,0007.88%
Boxer Capital, LLC 2,154,058$41,035,0002.31%
TANG CAPITAL MANAGEMENT LLC 937,500$17,859,0002.19%
RA Capital Management 4,417,259$84,149,0001.80%
BVF INC/IL 1,810,835$34,496,0001.42%
Zebra Capital Management LLC 12,271$234,0000.89%
Integral Health Asset Management, LLC 195,000$3,715,0000.72%
Prairiewood Capital, LLC 32,269$615,0000.51%
DAFNA Capital Management LLC 97,560$1,859,0000.50%
View complete list of ITEOS THERAPEUTICS INC shareholders